Identification of the risk for liver fibrosis on CHB patients using an artificial neural network based on routine and serum markers

Identification of the risk for liver fibrosis on CHB patients using an artificial neural network based on routine and serum markers

<p>Abstract</p> <p>Background</p> <p>Liver fibrosis progression is commonly found in patients with CHB. Liver biopsy is a gold standard for identifying the extent of liver fibrosis, but has many draw-backs. It is essential to construct a noninvasive model to predict the...

Full description

Bibliographic Details
Main Authors: Wang Danan, Wang Qinghui, Shan Fengping, Liu Beixing, Lu Changlong
Format: Article
Language:English
Published: BMC 2010-08-01
Series:BMC Infectious Diseases
Online Access:http://www.biomedcentral.com/1471-2334/10/251

Similar Items

Similar Items